FBXO22 mediates lys-63-linked liver kinase B1 (LKB1) polyubiquitination and inhibits its kinase activity, thereby inhibiting nonsmall-cell lung cancer (NSCLC) cell growth (10). The gene discussed is FBXO22; the disease is non-small cell lung carcinoma.